Amgen/ US0311621009 /
7/8/2025 8:12:07 PM | Chg. +3.82 | Volume | Bid7/8/2025 | Ask7/8/2025 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
296.71USD | +1.30% | 20,114 Turnover: 5.95 mill. |
296.52Bid Size: 102 | 296.87Ask Size: 100 | 159.4 bill.USD | 3.08% | 38.90 |
GlobeNewswire
8:22 PM
Market Barriers Continue to Challenge PNH Treatment Optimization Despite Emerging Options, According...
GlobeNewswire
7/7
Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chi...
GlobeNewswire
7/3
Oxford BioTherapeutics Announces Third Oncology Drug Candidate from Boehringer Ingelheim Collaborati...
GlobeNewswire
7/2
Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics
GlobeNewswire
7/1
Outlook Therapeutics Appoints Biopharmaceutical Industry and Commercial Leader Bob Jahr as Chief Exe...
GlobeNewswire
7/1
Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advis...
GlobeNewswire
6/18
Aisera Introduces a System of AI Agents for Faster, Smarter Enterprise Transformation
GlobeNewswire
6/18
Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to Board of Directors
GlobeNewswire
6/18
TOLREMO therapeutics Announces Strengthening of Leadership: Alessandra Cesano Joins Board of Directo...
GlobeNewswire
6/17
Cardiff Oncology Appoints Dr. Roger Sidhu as Chief Medical Officer and Announces Timing for the Next...
GlobeNewswire
6/17
Saudi Arabia Introduces Strategic Healthcare Vision and Global Partnerships at BIO 2025
GlobeNewswire
6/16
Saudia Arabia Introduces Strategic Healthcare Vision and Global Partnerships at BIO 2025
GlobeNewswire
6/9
Lyell Immunopharma Strengthens Clinical and Commercial Capabilities with Key Board and Executive App...
GlobeNewswire
6/2
Ardelyx Appoints Mike Kelliher Chief Business Officer and James P. Brady Chief Human Resources Offic...
GlobeNewswire
6/2
Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable...